Clinical Trial Update: TL-895 and KRT-232 Study in Acute Myeloid Leukemia [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for TL-895 and KRT-232 in Acute Myeloid Leukemia, covering Phase 1 and Phase 2 studies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• KRT-232
• TL-895

Snippet

Sponsor: Telios Pharma, Inc. | Conditions: Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: UNKNOWN